The 5% of CML patients do not possess the BCR-ABL oncogene and are affected by atypical myeloid leukemia27, recently renamed MDS/MPN with neutrophilia28,29. This evidence concerns the gene ABL1 and chronic myelogenous leukemia, BCR-ABL1 positive.